The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASH 2015 | The Myeloma 2016 meeting: Integrating science and clinical practice
At the 58th American Society of Hematology (ASH) Annual Meeting & Exposition, Keith Stewart, MB, ChB, from Mayo Clinic, Scottsdale, AZ, discusses the upcoming Myeloma 2016 meeting, which will be held in Boston during April 2016. The meeting provides a platform for high-level discussion between globally recognised clinicians and researchers in the field of multiple myeloma, and topics will include genomics, minimal residual disease, immuno-oncology and new therapeutic targets.
